Shanghai Henlius Biotech Catalyst Calendar
Proactively evaluate Shanghai Henlius Biotech Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Shanghai Henlius Biotech Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 31 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 20 Nov 2019 | Phase II Trial Initiation | Henlix Biotech Inc | - | serplulimab | Infectious Disease | Hepatitis B | Clinical Trial Registry |
| 15 Nov 2019 | Phase III Trial Initiation | Novotech Australia Pty Ltd; Shanghai Henlius Biotech Inc | 2696 | serplulimab | Oncology | Gastric Cancer | Clinical Trial Registry |
| 15 Nov 2019 | Phase II Trial Initiation | Shanghai Henlius Biotech Inc | 2696 | serplulimab | Oncology | Cervical Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer